Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.740
+0.060 (1.28%)
At close: Nov 7, 2025, 4:00 PM EST
4.530
-0.210 (-4.43%)
After-hours: Nov 7, 2025, 4:10 PM EST
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $152.84 million as of November 7, 2025. Its market cap has decreased by -30.10% in one year.
Market Cap
152.84M
Enterprise Value
24.72M
1-Year Change
-30.10%
Ranking
Category
Stock Price
$4.74
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $152.84M, a decrease of -74.33%. That is a compound annual growth rate of -16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 171.43M | 3.89% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -8.03% |
| Dec 30, 2020 | 684.44M | 75.63% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |